MAPT and Alzheimer disease: In order to explore the molecular mechanism of RP11-59J16.2 in the development of AD, western blot assay was used to detect the effect of RP11-59J16.2/MCM2 on the phosphorylation of Tau, as showed in Figure 6A and Figure 6C.